Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enzootic is a biotechnology company pioneering genetic and reproductive solutions for the aquaculture industry, specifically focusing on decapod crustaceans like shrimp and prawns. The company's core innovation is a proprietary, non-GMO platform for producing all-female populations through parental cell transplantation, which exploits the natural sexual plasticity of these species. By producing monosex populations, Enzootic enables farmers to achieve higher yields, better feed conversion ratios, and more uniform harvests, as females in many species grow significantly faster than males. Headquartered in Israel with significant operations in Thailand, the company is scaling its technology to address the global demand for sustainable and efficient seafood production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enzootic.